Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Maturitas|December 6, 2005
Behaviour of some indicators of oxidative stress in postmenopausal and fertile womenSalvatore Santo Signorelli, Sergio Neri, Salvatore Sciacchitano, et al.
Angiology|February 19, 2016
Plasma Levels of Inflammatory Biomarkers in Peripheral Arterial Disease: Results of a Cohort StudySalvatore Santo Signorelli, Massimiliano Anzaldi, Massimo Libra, et al.
Journal of Hepatology|August 11, 2012
Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statementMartin Schaefer, Lucile Capuron, Astrid Friebe, et al.
Clinical Therapeutics|December 22, 2005
Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controlsSergio Neri, Salvatore S Signorelli, Benedetto Torrisi, et al.
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|September 4, 2012
Carotid intima-media thickness and liver histology in hemodialysis patients with nonalcoholic Fatty liver diseaseSergio Neri, S S Signorelli, R Scuderi, et al.
Drugs & Aging|April 13, 2006
A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysisSalvatore Santo Signorelli, Pasquale Fatuzzo, Francesco Rapisarda, et al.
Kidney & Blood Pressure Research|July 1, 2006
Propionyl-L-carnitine therapy: effects on endothelin-1 and homocysteine levels in patients with peripheral arterial disease and end-stage renal diseaseSalvatore Santo Signorelli, Pasquale Fatuzzo, Francesco Rapisarda, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 20, 2011
The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirinMichele Malaguarnera, Marco Vacante, Gaetano Bertino, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 18, 2003
Can ultrasonographic findings of perihepatic lymphadenopathy promote investigations to detect possible presence of virus C infection in non-symptomatic subjects?Sergio Neri, Dario Ierna, Barbara Mauceri, et al.
The American Journal of Gastroenterology|September 10, 2022
Correction and Prevention of Hyponatremia in Patients With Cirrhosis and Ascites: Post Hoc Analysis of the ANSWER Study DatabaseGiacomo Zaccherini, Maurizio Baldassarre, Manuel Tufoni, et al.
Pageof 4